ArticleSleep & breathing = Schlaf & Atmung2026
Cutaneous silent period in patients with obstructive sleep apnea.
Article in Sleep & breathing = Schlaf & Atmung, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeEmpirical evidence suggests that the duration of the Cutaneous Silent Period (CuSP) is significantly extended in pathological states such as Idiopathic Parkinson's Disease (IPD), Restless Legs Syndrome (RLS), and dystonia, all of which are correlated with the degeneration of dopaminergic neurons. This neurodegenerative process is a critical factor in the etiology of Obstructive Sleep Apnea (OSA). In light of this active participation, the present study sought to assess the CuSP in patients with OSA.
methodsA cohort comprising forty individuals diagnosed with OSA and forty healthy controls, all of whom underwent polysomnographic assessments, was incorporated into this investigation. The study meticulously analyzed the onset time, termination time, and duration of the CuSP in both median nerves utilizing electromyographic techniques.
resultsIn the study examining the median nerve CuSP study, right and left CuSP was significantly prolonged in patients with OSA (p = 0.001, p < 0.001). Additionally, the onset time of the right and left CuSP was found to be shorter in the patient group (p = 0.017, p = 0.003).
conclusionThe findings indicate that the duration of the CuSP is significantly prolonged in patients with OSA, similar to observations in IPD, RLS and dystonia. These results highlight the potential clinical relevance of CuSP duration as a biomarker for OSA-related neuronal alterations.
Indexed as
Identifiers
42426471What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.